These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 10395680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.
    van Kuyk R, Torbett BE, Gulizia RJ, Leath S, Mosier DE, Koenig S.
    J Immunol; 1994 Nov 15; 153(10):4826-33. PubMed ID: 7963548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.
    Weekes MP, Carmichael AJ, Wills MR, Mynard K, Sissons JG.
    J Immunol; 1999 Jun 15; 162(12):7569-77. PubMed ID: 10358214
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85.
    Boggiano C, Moya R, Pinilla C, Bihl F, Brander C, Sidney J, Sette A, Blondelle SE.
    Eur J Immunol; 2005 May 15; 35(5):1428-37. PubMed ID: 15789356
    [Abstract] [Full Text] [Related]

  • 10. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
    Brander C, Goulder PJ, Luzuriaga K, Yang OO, Hartman KE, Jones NG, Walker BD, Kalams SA.
    J Immunol; 1999 Apr 15; 162(8):4796-800. PubMed ID: 10202022
    [Abstract] [Full Text] [Related]

  • 11. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS.
    J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R.
    Clin Immunol; 2001 Oct 01; 101(1):51-8. PubMed ID: 11580226
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005 Oct 01; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
    Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE.
    Eur J Immunol; 1997 Sep 01; 27(9):2323-9. PubMed ID: 9341776
    [Abstract] [Full Text] [Related]

  • 20. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
    van Baalen CA, Guillon C, van Baalen M, Verschuren EJ, Boers PH, Osterhaus AD, Gruters RA.
    Eur J Immunol; 2002 Sep 01; 32(9):2644-52. PubMed ID: 12207349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.